PushpaNarayanaswamiMDFAAN

Neuromuscular Medicine, Neurophysiology

Vice -Chair Clinical Operations, Department of Neurology, Beth Israel Deaconess Medical Center. Associate Professor of Neurology, Harvard Medical School, Boston MA

Join to view full profile

Dr. Narayanaswami is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Narayanaswami's full profile

Already have an account?

Office
330 Brookline Avenue,
BIDMC Neurology Shapiro Clinical Center
Boston, MA 02215
Phone+1 617-667-8130

Fax+1 617-667-3175

Summary

Dr. Pushpa Narayanaswami is a neurologist in Boston, MA and is affiliated with Beth Israel Deaconess Medical Center. She received her medical degree from Bangalore Medical College and has been in practice 34 years. She specializes in neuromuscular medicine and neurophysiology and is experienced in general neurology, electromyography, neuromuscular medicine, clinical neurophysiology, and neurohospitalist.

Education & Training

University of TennesseeResidency, Neurology, 1996 - 2000
University of TennesseeInternship, Internal Medicine, 1995 - 1996
Bangalore Medical CollegeClass of 1983

Certifications & Licensure

MA State Medical License 2006 - 2025
IA State Medical License 1997 - 2007
CA State Medical License 2000 - 2006
TN State Medical License 2000 - 2005
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

Jun Kimura Outstanding Educator American Association of Neuromuscular and Electrodiagnostic Medicine, 2019
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2012 Mar 01
Withdrawn
Phase 2
Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism Start of enrollment: 2012 Mar 01
Completed
Phase 2
Disease-Modifying Treatments for Myasthenia Gravis Start of enrollment: 2018 May 07
Completed

Publications & Presentations

PubMed

Efgartigimod alfa-fcab use in a pregnant woman with generalized myasthenia gravis: A case report.
Ryan Verity, Pushpa Narayanaswami
Muscle & Nerve. 2024-12-01
Patient and care partner perspectives and preferences related to myasthenia gravis treatment: A qualitative study.
Margaret Yung, Pushpa Narayanaswami, Jacqueline Pesa, Zia Choudhry, Louis Jackson
Health Science Reports. 2024-09-01
Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply.
Pushpa Narayanaswami, Donald B Sanders
The Lancet. Neurology. 2024-08-01

Press Mentions

AAN Practice Update: Discuss Thymectomy with Myasthenia Gravis PatientsJune 18th, 2020
Dr. Pushpa Narayanaswami Recognized as Top EducatorOctober 3rd, 2019
Guideline Offers Direction in Genetic Testing for Certain Types of Muscular DystrophyOctober 13th, 2014
Join now to see all

Committees

Member, Board of Directors, AANEM 2020 - Present
Chair, Quality Improvement and Patient Safety Committee, AANEM 2011 - Present
Member, Guideline Development Subcommittee of the American Academy of Neurology 2016 - 2021